The study of consistent properties of the vasopressin nasal dosage form

Authors

  • Al Nukarii Abdulkarim State Institution the «Dnepropetrovsk medical academy»,,
  • A. L. Drozdov State Institution the «Dnepropetrovsk medical academy»,,
  • A. P. Lysyanskaya Zaporizhzhia State Medical University,

DOI:

https://doi.org/10.14739/2409-2932.2016.3.77932

Keywords:

Arginine Vasopressin, Ointments, Thixotropy

Abstract

Evaluation of consistent properties is an important and integral part of investigations on the creation of semisolid nasal pharmacotherapeutic agents.

The aim of this work is the study of consistent properties of developed nasal semisolid dosage form with synthetic analogue of vasopressin – arginine-vasopressin for the treatment of cognitive consequences of cerebral-vascular pathology.

Materials and methods. The study of structural-mechanical characteristics of nasal ointment with 0.000005% arginine-vasopressin on the vaseline-lanolin-paraffin base was carried out by a rotary viscosimeter «Reotest-2» with cylindrical arrangement. It was established that consistent properties of arginine-vasopressin semisolid dosage form and «mechanical stability» (2.56) describe composition as a thixotropic system which provides with restorability after applying tension and allow to predict stability of consistent properties during a long-term storage. Calculated factors of dynamical flowing of arginine- vasopressin dosage form on the vaseline-lanolin-paraffin base (Кd1=28.7%; Kd2=53.84%) quantitatively confirm satisfactory spreading degree of the system during application on the mucous membranes or in manufacturing process.

Conclusions. The studies of consistent properties of nasal ointment with synthetic analogue of vasopressin – arginine-vasopressin 0.000005% on lipophilic basis for treatment of cognitive effects of cerebrovascular disease have been conducted by rotary viscometer «Reotest 2».

It has been established that consistent properties of studied soft nasal dosage form of arginine-vasopressin and «mechanical stability» value of the system (2.56) characterize it as a thixotropic, that assure recovery from mechanical stress, that allows to predict the stability of consistent properties of the composition during prolonged storage.

The calculated values of coefficients of dynamic flow of intranasal dosage form of arginine-vasopressin on vaseline-lanolin-paraffin base (Кd1=28.7%; Kd2=53.84%) quantitatively confirm satisfactory level of system distribution during application on mucous membranes or at manufacturing process operations.

References

Drozdov, A. L. (2015) Mnesticheskie e´ffekty peptidov vazopressinovogo ryada [Amnestic effects of peptides of the vasopressin series]. Dnepropetrovsk: Ekonomikas. [in Ukrainian].

Al Nukari, Abdulkarim, Svirhun, I. S., Lysianska, A. P., Rudko, A. M., & Melkonian, S. A. (2015) (patentee) Patent na korysnu model №103417 Ukraina, MPK A 61 K 38/00. Nazalna maz nootropnoi dii u 201507280 ; zayavl. 20.07.15 ; opubl. 10.12.15 [The patent for utility model №103417 Ukraine, IPC A 61 K 38/00. Nasal ointment of neuroprotective action. u 201507280; 7/20/15 stated; posted 10/12/15]. Biuleten, 23. [in Ukrainian].

Al Nukari, Abdulkarim, Svirhun, I. S., Lysianska, A. P., & Rudko, A. M. (2015) (patentee) Patent na korysnu model №103418 Ukraina, MPK A 61 K 38/00. Nazalna maz nootropnoi dii «Mnemastym». – u201014308 ; zaiavl. 20.07.15; opubl. 10.12.15 [The patent for utility model №103418 Ukraine, IPC A 61 K 38/00. Nasal ointment of neuroprotective action «Mnemastym»]. Biuleten, 23. [in Ukrainian].

Belokoskova, S. G., Stepanov, I. I., & Tsikunov, S. G. (2012) Agonist V2-receptorov vazopressina reduciruet depressivnye rasstrojstva u postinsul'tnykh bol'nykh [Agonist of У2 vasopressin receptor reduces depressive disorders in post-stroke patients]. Vestnik Rossijskoj akademii medicinskikh nauk, 4, 40–44. [in Russian].

Tsikunov, S. G., & Belokoskova, S. G. (2007) Psychophysiological analisis of the influence of vasopressin on speech in patients with post-stroke aphasias. Spanish J. Psychology, 10(1), 180–190. doi: http://dx.doi.org/10.1017/S1138741600006442.

Rogachev, I. O., Gladyishev, V. V., Burlaka, B. S., & Kechin, I. L. (2011) Sravnitelnye issledovaniya strukturno-mekhanicheskikh kharakteristik intranazal´nykh myagkikh lekarstvennykh form nimodipina [Comparative study of the structural - mechanical characteristics of the intranasal formulations of nimodipine soft]. Zaporozhskiо mediсinskiо zhurnal, 13(3), 92–94. [in Ukrainian].

Al Zedan Fadi, V. V. Gladyishev, B. S., & Burlaka, I. A. (2012) Biryuk izuchenie konsistentnykh svojstv intranazal´noj lekarstvennoj formy amlodipina [Study of consistency properties intranasal formulation of amlodipine]. Zaporozhskij medicinskiy zhurnal, 1(70), 55–57. [in Ukrainian].

Burlaka, B. S. (2015) Perspektyvy stvorennia intranazalnoho likarskoho zasobu na osnovi pryrodnoi syrovyny dlia kompleksnoi terapii alerhichnykh rynitiv [The Prospects of intranasal drug based on natural raw materials for the complex therapy of allergic rhinitis]. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 1, 48–50. [in Ukrainian].

Gladyshev, V. V., Kuchina, G. K., Burlaka, B. S., & Biryuk, I. A. (2013) Issledovanie reologicheskikh svojstv myagkoj nazal'noj lekarstvennoj formy diltiazema [Research on the Rheological properties of the soft nasal dosage form of diltiazem]. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 11, 69–72. [in Ukrainian].

Gladyshev, V. V. (1997) Teoreticheskoe i e´ksperimental´noe obosnovanie sozdaniya myagkikh lekarstvennykh form antimikoticheskogo dejstviya. (Dis… dokt. farm. nauk). [Theoretical and experimental study on the development of soft medicinal forms antimycotic action Dis. Dr. of farm. sci.]. Zaporozh’ye. [in Ukrainian].

Tencova, A. I., & Gretskij, V. M. (1980) Sovremennye aspekty issledovaniya i proizvodstva mazej [Modern aspects of exploration and production of ointments]. Moscow: Medicina.

Downloads

How to Cite

1.
Abdulkarim AN, Drozdov AL, Lysyanskaya AP. The study of consistent properties of the vasopressin nasal dosage form. Current issues in pharmacy and medicine: science and practice [Internet]. 2016Sep.22 [cited 2024Nov.13];9(3). Available from: http://pharmed.zsmu.edu.ua/article/view/77932

Issue

No. 3 (2016)

Section

Pharmaceutical manufacturing

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)